The DeGregorio Family for Gastric and Esophageal Cancer (Gastroesophageal Cancer) is pleased to announce its 13th annual funding opportunity for gastroesophageal malignancies in honor of Michael F. Price. The Foundation seeks to promote and facilitate collaborative research on the pathogenesis, early diagnosis and treatment of upper gastrointestinal malignancies. We support high quality, innovative and transformative translational and bench research to improve the understanding of the biology of these diseases, identification of potential novel therapeutic targets, or in the development and evaluation of novel biomarkers for early diagnosis and treatment. Pre-clinical research, basic mechanistic studies, genomic/epigenomic studies as well as epidemiologic studies may also be supported.
Funding: $250,000 over 2 years.
Indirect costs: 10%,
The deadline for applications is November 1, 2022. Funding period: January 15, 2023 – January 14, 2025. Winners announced: mid-January 2023.